Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.0041 | 0.9 |
mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |